Medical advisor endocrinology I saw this job posting few months ago filled some 3 months later. Initially I thought although Hybrid why based in Montreal? Anyway he seems to have the experience.."Strong scientific knowledge coupled with robust business acumen, strategic thinking, and advanced knowledge of Canadian drug development environment". Then one has to wonder now that they are going to commercial drugs in Canada why not adding Tesamorelin to the mix. They stopped selling the drug based on a "business decision" (below)most likely lower pricing in Canada and associated costs among others setting up a sale force, administrative costs, self managed centralized inventory(storage and distribution) or a third party distributor...as for logistic I believe Tesamorelin is manufactured locally in Montreal so less costly. Point is cost sharing might make it more feasible to restart the commercialization of the drug despite lower pricing and a small targeted market which was not cost efficient to commercialize alone but it can generate an adds on profit when the company has establish itself as commercial business in Canada!!
Discontinuation report EGRIFTA
Check out this job at Theratechnologies Inc.:
https://www.linkedin.com/jobs/view/3911887445
https://www.linkedin.com/in/christian-caldji-phd-597b7192?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app